Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
5000 participants
OBSERVATIONAL
2008-01-31
2050-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development of a Canadian Bronchiectasis and NTM Database
NCT06144996
The Incidence of Nontuberculous Mycobacterial Pulmonary Infection in Bilateral Bronchiectasis and Bronchiolitis
NCT01354912
The Establishment of China Bronchiectasis Registry and Research Collaboration
NCT03643653
Prevalence and Characteristics of Patients With Bronchiectasis Comorbid Nontuberculous Mycobacteria
NCT03594032
Health Impact of Non-Tuberculous Mycobacteria Pulmonary Disease (NTM-PD)
NCT07192705
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-CF Bronchiectasis Patients with or without NTM
Patients over the age of 18 with non-CF Bronchiectasis with or without Nontuberculosis Mycobacteria (NTM).
No interventions assigned to this group
Nontuberculosis Mycobacteria (NTM)
Patients over the age of 18 with Nontuberculosis Mycobacteria (NTM)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* non-CF Bronchiectasis
* Nontuberculosis Mycobacteria (NTM)
Exclusion Criteria
* CF Bronchiectasis
18 Years
120 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
COPD Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
COPD Foundation
Washington D.C., District of Columbia, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Delia Prieto
Role: CONTACT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BRR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.